Yang et al reported a prognostic score for a patient with newly diagnosed multiple myeloma with 1q+. 1a+ is a common high-risk cytogenetic abnormality which impacts survival. The authors are from Jilin University, Peking Union Medical College, Shanxi Medical University, Mayo Clinic and affiliated hospitals.
